Oramed Pharmaceuticals Inc. (ORMP) Social Stream



Oramed Pharmaceuticals Inc. (ORMP): $3.46

0.16 (+4.85%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add ORMP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#105 of 357

in industry

ORAMED PHARMACEUTICALS INC (ORMP) Price Targets From Analysts

Use the tables below to see what analysts covering ORAMED PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-02 3 $35 $17 $26.25 $2.34 1021.79%
2021-11-10 4 $38 $17 $30 $2.34 1182.05%
2022-01-18 3 $38 $30 $33.75 $2.34 1342.31%
2022-04-13 4 $38 $20 $31 $2.34 1224.79%
2022-04-27 3 $38 $20 $31 $2.34 1224.79%
2022-11-16 3 $38 $20 $30 $2.34 1182.05%
2022-11-21 3 $32 $20 $26.75 $2.34 1043.16%
2023-01-03 2 $32 $20 $26.75 $2.34 1043.16%
2023-01-13 3 $30 $3 $15.75 $2.34 573.08%
2023-01-25 2 $30 $2.8 $11.933 $2.34 409.96%
2023-10-05 2 $4.3 $3 $3.65 $2.34 55.98%

The Trend in the Analyst Price Target


Over the past 25 months, ORMP's average price target has gone down $19.35.

Over the past 39 weeks, ORMP's average upside potential has been 245.94%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-03 2 32.0 20.0 26.750 12.40 115.73%
2023-01-25 3 30.0 2.8 10.200 2.06 395.15%
2023-01-25 3 30.0 2.8 11.933 2.06 479.27%
2023-01-25 3 3.0 2.8 2.900 2.06 40.78%
2023-10-05 2 4.3 3.0 3.650 2.39 52.72%

ORMP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 2 0 0 2

The Trend in the Broker Recommendations


Over the past 23 months, ORMP's average broker recommendation rating worsened by 1.75.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ORMP as an investment opportunity.

  • In the context of all US stocks, ORAMED PHARMACEUTICALS INC's number of analysts covering the stock is greater than 110.41% of them.
  • ORAMED PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1385.93% of all US stocks.
  • In the context of stocks in the small market cap category, ORAMED PHARMACEUTICALS INC's average analyst price target is higher than 841.22% of them.
  • In terms of how ORAMED PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -566.79% of that group.

In the Pharmaceutical Products industry, FBRX, BYSI, and CKPT are the three stocks most similar to ORAMED PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding ORMP using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!